AI assistant
Ocugen, Inc. — Director's Dealing 2021
Oct 27, 2021
32915_dirs_2021-10-27_e048ff48-88c6-4d56-8025-2657d2f58108.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-10-25
Reporting Person: Kompella Uday (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-25 | Common Stock | S | 46371 | $9.08 | Disposed | 229416 | Indirect |
| 2021-10-26 | Common Stock | S | 25000 | $12.05 | Disposed | 204416 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 550674 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.36. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.